Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP1₄₂-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults

• Ruth D. Ellis ,

  * E-mail: ellisru@niaid.nih.gov

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Laura B. Martin,

  Current address: Novartis Vaccines Institute for Global Health, Siena, Italy

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Donna Shaffer,

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Carole A. Long,

  Affiliation Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Kazutoyo Miura,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Michael P. Fay,

  Affiliation Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• David L. Narum,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Daming Zhu,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Gregory E. D. Mullen,

  Current address: The Rayne Institute, Division of Imaging Sciences, School of Medicine, King's College London, United Kingdom

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Siddhartha Mahanty,

  Current address: Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Louis H. Miller,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Anna P. Durbin

  Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯